Navigation Links
Childhood cancer research grant awarded to the Research Institute at Nationwide Children's Hospital
Date:1/17/2012

It takes life-saving research and access to clinical trials to help children with cancer. The St. Baldrick's Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, awarded an infrastructure grant of $47,000 to the Biopathology Center (BPC), housed in The Research Institute at Nationwide Children's Hospital. The Foundation's infrastructure grants provide institutions with resources to enable them to conduct more research and enroll more kids in ongoing clinical trials their best hope for a cure.

Worldwide, more than 160,000 children are diagnosed with cancer each year and it remains the leading cause of death by disease among children in the United States. With only 4 percent of all federal cancer research funding dedicated to pediatric cancer research, and more than 70 percent of children receiving treatment through clinical trials, St. Baldrick's Foundation infrastructure grants are critical to finding cures for all childhood cancers.

"We are very thankful for the recent award provided to us by the St. Baldrick's Foundation," said Nilsa C. Ramirez, M.D., Medical Director of the BPC and Director of Surgical Pathology in the Department of Pathology and Laboratory Medicine at Nationwide Children's. "This award will be used to purchase the Cray CX1-iWS system to act as a Digital Pathology Analytics Engine (DPAE), providing an electronic quality assurance program. This system will analyze tissue images using computer algorithms that have been built and tested at our BPC. As new images are generated, the DPAE will automatically review and identify flaws prior to sharing images with the expert pathologists. The use of the DPAE will significantly accelerate the pace of providing high quality whole slide images by reducing technician time and allowing us to automatically evaluate image quality. These images are analyzed for various purposes, including evaluation of material used in cutting edge pediatric translational research efforts, many associated with Children's Oncology Group (COG) sponsored clinical treatment trials."

Ramirez, who is also on the faculty of The Ohio State University College of Medicine, explained that the BPC currently utilizes 10 imaging robots to generate whole slide images for several National Cancer Institute sponsored translational research efforts and three cancer cooperative groups, including the COG. Some of the more sophisticated equipment that complements the robots was also purchased in previous years using similar St. Baldrick's Foundation awards. The addition of the DPAE will allow the BPC to efficiently utilize the imaging robots and improve the turn-around time of the quality assurance process. These virtual images will subsequently be shared with expert pathologists via the Virtual Imaging for Pathology, Education & Research (VIPER) web-based application developed by the BPC.

"For us, it is an honor to be the recipient of St. Baldrick's Foundation infrastructure grants, as these awards assist us in providing cutting edge digital pathology services to numerous national and international investigators involved in pediatric oncology research," Ramirez added.

The infrastructure grants, combined with the more than $19.6 million awarded in June, bring the St. Baldrick's Foundation's funding total to more than $21 million awarded in 2011. Infrastructure grants were awarded based on the need of the institution and its patients, anticipated results of the grant and local participation in St. Baldrick's events.


'/>"/>
Contact: Erin Pope
Erin.Pope@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Related medicine news :

1. Gene identified as a new target for treatment of aggressive childhood eye tumor
2. Childhood hypersensitivity linked to OCD
3. Childhood cancer drugs cure now, may cause problems later, UB research shows
4. Birth Defects Seem Rare in Kids of Childhood Cancer Survivors
5. Childhood cancer survivors exposure to chemotherapy, radiation does not increase risk of birth defects in their children
6. Abuse in Childhood May Alter Teen Brain
7. Parents views sought on childhood obesity risk
8. Childhood Aggression May Predict Health Woes in Adulthood
9. California making headway in battle against childhood obesity but successes are uneven
10. In a childhood cancer, basic biology offers clues to better treatments
11. NIH scientists discover link among spectrum of childhood diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
Breaking Medicine Technology: